Pharsight

Drugs that contain Albuterol Sulfate; Ipratropium Bromide

1. Combivent patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5603918 BOEHRINGER INGELHEIM Aerosol composition of a salt of ipratropium and a salt of albuterol
Jun, 2015

(9 years ago)

Market Authorisation Date: 24 October, 1996

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

COMBIVENT family patents

Family Patents

2. Combivent Respimat patents expiration

COMBIVENT RESPIMAT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5497944 BOEHRINGER INGELHEIM Atomising devices and methods
Mar, 2013

(11 years ago)

US6007676 BOEHRINGER INGELHEIM Atomizing nozzle and filter and spray generating device
Sep, 2013

(10 years ago)

US6503362 BOEHRINGER INGELHEIM Atomizing nozzle an filter and spray generating device
Sep, 2013

(10 years ago)

US5911851 BOEHRINGER INGELHEIM Atomizing nozzle and filter and spray generating device
Sep, 2013

(10 years ago)

US5472143 BOEHRINGER INGELHEIM Atomising nozzle and filter and spray generation device
Sep, 2013

(10 years ago)

US5662271 BOEHRINGER INGELHEIM Atomizing devices and methods
Sep, 2014

(9 years ago)

US7246615 BOEHRINGER INGELHEIM Atomising nozzle and filter and spray generating device
May, 2016

(8 years ago)

US5964416 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6176442 BOEHRINGER INGELHEIM Device for mounting a component exposed to a pressurized fluid
Oct, 2016

(7 years ago)

US7104470 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6726124 BOEHRINGER INGELHEIM Device for producing high pressure in a fluid in miniature
Oct, 2016

(7 years ago)

US6453795 BOEHRINGER INGELHEIM Locking mechanism for a spring-actuated device
Dec, 2016

(7 years ago)

US6149054 BOEHRINGER INGELHEIM Mechanical counter for a metering apparatus
Dec, 2016

(7 years ago)

US6977042 BOEHRINGER INGELHEIM Microstructured filter
Aug, 2018

(5 years ago)

US6846413 BOEHRINGER INGELHEIM Microstructured filter
Aug, 2018

(5 years ago)

US7802568 BOEHRINGER INGELHEIM Cartridge for a liquid
Feb, 2019

(5 years ago)

US6988496 BOEHRINGER INGELHEIM Cartridge for a liquid
Feb, 2020

(4 years ago)

US7988001 BOEHRINGER INGELHEIM Container provided with a pressure equalization opening
Aug, 2021

(2 years ago)

US7284474 BOEHRINGER INGELHEIM Piston-pumping system having o-ring seal properties
Aug, 2024

(2 months from now)

US7896264 BOEHRINGER INGELHEIM Microstructured high pressure nozzle with built-in filter function
May, 2025

(11 months from now)

US7396341 BOEHRINGER INGELHEIM Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Oct, 2026

(2 years from now)

US9027967 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2027

(2 years from now)

US7837235 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2028

(3 years from now)

US8733341 BOEHRINGER INGELHEIM Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Oct, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Oct 07, 2014

Market Authorisation Date: 07 October, 2011

Treatment: NA

Dosage: SPRAY, METERED;INHALATION

How can I launch a generic of COMBIVENT RESPIMAT before it's drug patent expiration?
More Information on Dosage

COMBIVENT RESPIMAT family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Duoneb patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6632842 MYLAN SPECIALITY LP Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
Dec, 2021

(2 years ago)

Market Authorisation Date: 21 March, 2001

Treatment: Treatment of bronchospasm associated with copd in patients requiring more than one broncho dilator

Dosage: SOLUTION;INHALATION

How can I launch a generic of DUONEB before it's drug patent expiration?
More Information on Dosage

DUONEB family patents

Family Patents